Results 21 to 30 of about 140,485 (324)
BACKGROUND: Management options for placenta accreta spectrum disorder are multiple, without a clear picture of which one is superior. Management guidelines describe the use of a wide range of human and technological resources that are not always ...
Albaro José Nieto-Calvache, MD +4 more
doaj +1 more source
The clinical management of placenta accreta spectrum (PAS) depends on placental topography and vascular involvement. Our aim was to determine whether transabdominal and transvaginal ultrasound signs can predict PAS management.
R. Aryananda +5 more
semanticscholar +1 more source
Clinical value of serum VEGF and sFlt-1 in pernicious placenta previa
This study was designed to explore the expression and the diagnostic value of vascular endothelial growth factor (VEGF) and soluble fms-like tyrosine kinase-1 (sFlt-1) in pernicious placenta previa (PPP) combined placental accreta/increta. A total of 140
Na Wang, Dandan Shi, Na Li, Hongyuan Qi
doaj +1 more source
Ultrasound scoring system for prenatal diagnosis of placenta accreta spectrum
Background To develop an ultrasound scoring system for placenta accreta spectrum (PAS), evaluate its diagnostic value, and provide a practical approach to prenatal diagnosis of PAS.
Junling Zhang +5 more
semanticscholar +1 more source
Introduction: Placenta accreta spectrum disorders are among the leading causes of maternal morbidity and mortality and their prevalence is likely to increase in the future.
Margarida Cal +3 more
doaj +1 more source
Objective To evaluate the diagnostic accuracy of ultrasound and in the diagnosis of Placenta accreta spectrum (PAS). Data sources Screening of MEDLINE, CENTRAL, other bases from inception to February 2022 using the keywords related to placenta accreta ...
A. Maged +14 more
semanticscholar +1 more source
Placenta accreta index as a predictor of placental invasion in cases of placenta previa
Objective This study aims to evaluate the role of the placenta accreta index in predicting placental invasion in patients with placenta previa. Patients and methods This study was carried on 60 pregnant women with placenta previa (after 30 weeks ...
Ibrahim M El-Maghraby, Ahmed A Badr
doaj +1 more source
To report on the occurrence of urological complications in women undergoing Cesarean section for placenta accreta spectrum disorders (PAS).
Jauniaux Eric Orcid +11 more
semanticscholar +1 more source
To compare maternal outcome measures in surgical management of placenta accreta spectrum (PAS)—the modified one‐step conservative uterine surgery (MOSCUS), a new approach at Tu Du Hospital in Vietnam, versus cesarean hysterectomy, and to identify factors
A. Vuong +10 more
semanticscholar +1 more source
Clinical Diagnosis of Placenta Accreta and Clinicopathological Outcomes [PDF]
Objective To investigate the association between the intraoperative diagnosis of placenta accreta at the time of cesarean hysterectomy and pathological diagnosis.
Cahill, Alison G. +5 more
core +1 more source

